• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗N-甲基-D-天冬氨酸受体抗体脑炎患者的肾脏影响

The Effect on the Kidney in Patients With Anti-N-methyl D-aspartate Receptor Antibody Encephalitis.

作者信息

Liu Lizhi, Gu Meifeng, Liu Jia, Liu Qing, Xu Xiaofeng, Fan Rong, Peng Fuhua, Jiang Ying

机构信息

Department of Neurology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Neurology, Huizhou Hospital of Traditional Chinese Medicine, Huizhou, China.

出版信息

Front Neurol. 2021 Feb 12;12:601495. doi: 10.3389/fneur.2021.601495. eCollection 2021.

DOI:10.3389/fneur.2021.601495
PMID:33643189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907499/
Abstract

The function of the N-methyl-D-aspartate receptor (NMDAR) in the kidney has been studied. However, the effect on the kidney from anti-NAMDAR antibody encephalitis has not been investigated thus far. Case data were collected from 82 patients with anti-NMDAR antibody encephalitis and 166 age- and sex-matched healthy controls (HCs). Clinical characteristics, urinalysis [including urine pH and urine specific gravity (SG)], serum creatinine (Scr), and estimated glomerular filtration rate (eGFR) based on Cr levels were evaluated. At initial admission, urine pH levels and urine SG levels in anti-NMDAR antibody encephalitis patients were significantly higher and lower, respectively, than HCs (both < 0.001). There were no significant differences in Scr and eGFR between anti-NMDAR antibody encephalitis patients and HCs. Urine pH levels in patients with anti-NMDAR antibody <1:32 were significantly lower than those in patients with anti-NMDAR antibody ≥1:32 ( = 0.029). Urine pH levels were significantly lower ( = 0.004) and urine SG levels were significantly higher ( = 0.027) in a follow-up evaluation 3 months after treatment. The changes in urinalysis occur in patients with anti-NMDAR antibody encephalitis. The pathophysiological changes in anti-NMDAR antibody encephalitis were not limited to the CNS.

摘要

N-甲基-D-天冬氨酸受体(NMDAR)在肾脏中的功能已得到研究。然而,抗NMDAR抗体脑炎对肾脏的影响迄今尚未得到研究。收集了82例抗NMDAR抗体脑炎患者和166例年龄及性别匹配的健康对照者(HCs)的病例数据。评估了临床特征、尿液分析[包括尿液pH值和尿比重(SG)]、血清肌酐(Scr)以及基于Cr水平的估算肾小球滤过率(eGFR)。在初次入院时,抗NMDAR抗体脑炎患者的尿液pH值水平显著高于HCs,而尿比重水平则显著低于HCs(均P<0.001)。抗NMDAR抗体脑炎患者与HCs之间的Scr和eGFR无显著差异。抗NMDAR抗体<1:32的患者尿液pH值水平显著低于抗NMDAR抗体≥1:32的患者(P=0.029)。治疗后3个月的随访评估中,尿液pH值水平显著降低(P=0.004),尿比重水平显著升高(P=0.027)。抗NMDAR抗体脑炎患者会出现尿液分析的变化。抗NMDAR抗体脑炎的病理生理变化并不局限于中枢神经系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/7f0d4b51329c/fneur-12-601495-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/c948e1c03ef5/fneur-12-601495-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/2ae383e3491e/fneur-12-601495-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/0112a8550e24/fneur-12-601495-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/7f0d4b51329c/fneur-12-601495-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/c948e1c03ef5/fneur-12-601495-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/2ae383e3491e/fneur-12-601495-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/0112a8550e24/fneur-12-601495-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf7/7907499/7f0d4b51329c/fneur-12-601495-g0004.jpg

相似文献

1
The Effect on the Kidney in Patients With Anti-N-methyl D-aspartate Receptor Antibody Encephalitis.抗N-甲基-D-天冬氨酸受体抗体脑炎患者的肾脏影响
Front Neurol. 2021 Feb 12;12:601495. doi: 10.3389/fneur.2021.601495. eCollection 2021.
2
Elevated Plasma Homocysteine Levels in Anti-N-methyl-D-aspartate Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎患者血浆同型半胱氨酸水平升高
Front Neurol. 2019 May 3;10:464. doi: 10.3389/fneur.2019.00464. eCollection 2019.
3
Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎患者中中等长度抗神经丝自身抗体的鉴定
J Clin Neurol. 2020 Jul;16(3):470-479. doi: 10.3988/jcn.2020.16.3.470.
4
High serum creatinine is associated with reduction of psychiatric symptoms in female patients with anti-NMDAR encephalitis.血清肌酐水平升高与抗 NMDAR 脑炎女性患者精神症状的改善有关。
Neurosci Lett. 2021 Feb 16;746:135650. doi: 10.1016/j.neulet.2021.135650. Epub 2021 Jan 21.
5
Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.抗 N-甲基-D-天冬氨酸受体脑炎患者的临床特征和预后。
Neurocrit Care. 2018 Oct;29(2):264-272. doi: 10.1007/s12028-018-0536-6.
6
Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.血清胱抑素 C 与抗 N-甲基-D-天冬氨酸受体脑炎。
Acta Neurol Scand. 2018 May;137(5):515-522. doi: 10.1111/ane.12894. Epub 2018 Jan 7.
7
Serum complement levels in anti-N-methyl-d-aspartate receptor encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎患者的血清补体水平。
Eur J Neurol. 2018 Jan;25(1):178-184. doi: 10.1111/ene.13495. Epub 2017 Nov 17.
8
Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis.血清尿酸与抗N-甲基-D-天冬氨酸受体脑炎
Neurochem Int. 2017 Sep;108:34-39. doi: 10.1016/j.neuint.2017.02.005. Epub 2017 Feb 10.
9
Serum Bilirubin and Albumin in Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎患者的血清胆红素和白蛋白。
Neuroimmunomodulation. 2018;25(4):206-214. doi: 10.1159/000494801. Epub 2018 Nov 29.
10
Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎患者的脂质代谢
Neuroimmunomodulation. 2017;24(4-5):256-263. doi: 10.1159/000485623. Epub 2018 Feb 1.

本文引用的文献

1
Pathological Findings in Male Patients With Anti-N-methyl-d-Aspartate Receptor Encephalitis.抗N-甲基-D-天冬氨酸受体脑炎男性患者的病理检查结果
J Neuropathol Exp Neurol. 2019 Aug 1;78(8):735-741. doi: 10.1093/jnen/nlz052.
2
Extra-central nervous system target for assessment and treatment in refractory anti-N-methyl-d-aspartate receptor encephalitis.难治性抗N-甲基-D-天冬氨酸受体脑炎的中枢神经系统外评估与治疗靶点
J Crit Care. 2017 Feb;37:234-236. doi: 10.1016/j.jcrc.2016.09.016. Epub 2016 Sep 22.
3
A clinical approach to diagnosis of autoimmune encephalitis.
自身免疫性脑炎的临床诊断方法
Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20.
4
Blockade of the N-Methyl-D-Aspartate Glutamate Receptor Ameliorates Lipopolysaccharide-Induced Renal Insufficiency.N-甲基-D-天冬氨酸谷氨酸受体阻断可改善脂多糖诱导的肾功能不全。
PLoS One. 2015 Jul 2;10(7):e0132204. doi: 10.1371/journal.pone.0132204. eCollection 2015.
5
Glutamate receptors in the kidney.肾脏中的谷氨酸受体。
Nephrol Dial Transplant. 2015 Oct;30(10):1630-8. doi: 10.1093/ndt/gfv028. Epub 2015 Mar 31.
6
The potential of targeting NMDA receptors outside the CNS.靶向中枢神经系统以外的N-甲基-D-天冬氨酸受体的潜力。
Expert Opin Ther Targets. 2015 Mar;19(3):399-413. doi: 10.1517/14728222.2014.983900. Epub 2014 Dec 13.
7
Developmental changes in renal tubular transport-an overview.肾小管转运的发育变化——概述
Pediatr Nephrol. 2015 Dec;30(12):2085-98. doi: 10.1007/s00467-013-2666-6. Epub 2013 Nov 20.
8
N-methyl-D-aspartate receptor subunit NR3a expression and function in principal cells of the collecting duct.N-甲基-D-天冬氨酸受体亚单位 NR3a 在集合管主细胞中的表达和功能。
Am J Physiol Renal Physiol. 2011 Jul;301(1):F44-54. doi: 10.1152/ajprenal.00666.2010. Epub 2011 Mar 23.
9
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.抗 NMDAR 脑炎患者的临床经验和实验室研究。
Lancet Neurol. 2011 Jan;10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2.
10
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.脑炎的病因及其在英国的临床表现差异:一项多中心、基于人群的前瞻性研究。
Lancet Infect Dis. 2010 Dec;10(12):835-44. doi: 10.1016/S1473-3099(10)70222-X. Epub 2010 Oct 15.